,i #aagth ,,congress #b;d ,session ,h4 ,r4 #hddj ,,in ,,the ,,house ,,of ,,representatives ,july #bj1 #bjbb,mr4 ,blumenauer 7for himself1 ,ms4 ,mace1 ,ms4 ,dean1 ,mr4 ,biggs1 and ,mr4 ,correa7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on the ,judiciary1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to clarify that the ,federal ,right to ,try law applies to schedule ,i substances for which a phase ,i clinical trial has been completed and to provide access for eligible patients to such substances pursuant to the ,federal ,right to ,try law4 #a4 ,short title ,this ,act may be cited as the ,right to ,try ,clarification ,act4 #b4 ,findings ,congress finds as follows3 7#a7 ,the ,trickett ,wendler1 ,frank ,mongiello1 ,jordan ,mc,linn1 and ,matthew ,bellina ,right to ,try ,act of #bjag 7,public ,law #aae-agf7 was enacted in #bjah4 7#b7 ,section #efa;,b of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;bbb-#j;a71 as added by the ,act described in paragraph 7#a7 7referred to in this section as the ,federal ,right to ,try law71 does not exclude from the application of such law schedule ,i substances for which a phase ,i clinical trial has been completed4 7#c7 ,multiple schedule ,i drugs have progressed through phase ,i clinical trials and have been designated by the ,food and ,drug ,administration as breakthrough therapies under section #ejf of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cef7 because of preliminary clinical evidence indicating that such drugs demonstrate substantial improvement over existing therapies1 but eligible patients have not been permitted access to these drugs pursuant to the ,federal ,right to ,try law4 #c4 ,amendment to ,federal ,right to ,try law ,section #efa;,b7b7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;bbb-#j;a7b77 is amended by inserting any provision of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hja et seq47 that prohibits the unauthorized use1 possession1 distribution1 dispensation1 or transportation of an eligible investigational drug1 before and parts4